B2. Operating expenses
Operating expenses by function and type of cost
SEKm |
2017 |
2016 |
2015 |
IS Cost of goods sold |
–76,899 |
–72,438 |
–71,898 |
IS Sales, general and administration |
–19,130 |
–16,965 |
–16,216 |
IS Amortization of acquisition-related intangible assets |
–560 |
–159 |
–133 |
IS TB2:1 Items affecting comparability |
–940 |
–2,825 |
–786 |
Total |
–97,529 |
–92,387 |
–89,033 |
Refer also to chapter Description of costs for a description of costs.
SEKm |
Note |
2017 |
2016 |
2015 |
||||
|
||||||||
TB2:2 Other income |
|
1,045 |
970 |
923 |
||||
Change in inventory of finished products and products in progress1) |
|
172 |
–82 |
640 |
||||
Raw materials and consumables1) |
|
–38,191 |
–36,442 |
–37,271 |
||||
Personnel costs1) |
–20,142 |
–17,983 |
–16,943 |
|||||
TB2:3 Other operating expenses1) |
|
–34,444 |
–33,242 |
–31,654 |
||||
Amortization of intangible assets1) |
–853 |
–380 |
–275 |
|||||
Depreciation of property, plant and equipment1) |
–4,871 |
–4,764 |
–4,489 |
|||||
Impairment of intangible assets1) |
–132 |
–137 |
–497 |
|||||
Impairment of property, plant and equipment1) |
–254 |
–420 |
–375 |
|||||
Impairment of associates1) |
|
– |
– |
–62 |
||||
Gain on sale of securities1) |
|
– |
– |
970 |
||||
Revaluation of previously owned shares in associates1) |
72 |
– |
0 |
|||||
Gain on divestment1)2) |
|
69 |
93 |
– |
||||
Total |
|
–97,529 |
–92,387 |
–89,033 |
TB2:1 Items affecting comparability
SEKm |
2017 |
2016 |
2015 |
Impairment of inventory of finished products and products in progress |
–4 |
–156 |
–29 |
Raw materials and consumables |
– |
–102 |
–16 |
Personnel costs |
–69 |
–76 |
–295 |
Other operating expenses |
–620 |
–1,948 |
–482 |
Amortization of intangible assets |
–2 |
–43 |
– |
Depreciation of property, plant and equipment |
– |
–36 |
– |
Impairment of intangible assets |
–132 |
–137 |
–497 |
Impairment of property, plant and equipment |
–254 |
–420 |
–375 |
Impairment of associates |
– |
– |
–62 |
Revaluation of previously owned shares in associates |
72 |
– |
– |
Gain on divestment |
69 |
93 |
– |
Gain/loss on sale of securities |
– |
– |
970 |
Total |
–940 |
–2,825 |
–786 |
SEKm |
2017 |
Costs of split of SCA into two listed companies |
–550 |
Integration and transaction costs related to the acquisition of BSN medical and inventory valuation arising from acquisition balance |
–435 |
Closure of tissue production plant in the US |
–255 |
Restructuring costs for the closure of the tissue machine in the UK |
–75 |
Reversal of provisions for competition case in Poland |
265 |
Other |
110 |
Total |
–940 |
In 2016, items affecting comparability related mainly to costs for legal disputes (SEK –1,086m), cost for the closure of tissue production plants in Spain and France (SEK –757m), the closure of the business in India (SEK –374m) and the baby diaper business in Mexico (SEK –174m), costs in connection with acquisition of Wausau Paper Corp. (SEK –204m), transaction costs for BSN medical (SEK –143m) and other costs (SEK –87m).
In 2015, items affecting comparability related mainly to costs for the impairment of trademarks associated with the baby diaper business in Mexico and the Everbeauty acquisition in Taiwan (SEK –465m), impairment of non-current assets mainly used in tissue production in France and baby diapers in Mexico (SEK –375m), integration cost in conjunction with the acquisition of Georgia Pacific (SEK –440m), costs in conjunction with the divestment of the business jet operation (SEK –170m), a gain from the sale of securities (SEK 970m) and other items (SEK 306m), which include transaction costs.
For information on items affecting comparability by segment, refer to Note B1 Segment reporting.
SEKm |
2017 |
2016 |
2015 |
Sales not included in core operations |
1,045 |
970 |
923 |
Total |
1,045 |
970 |
923 |
SEKm |
2017 |
2016 |
2015 |
||
|
|||||
Transport expenses |
–7,425 |
–7,120 |
–7,108 |
||
Energy costs1) |
–4,498 |
–4,448 |
–4,925 |
||
Purchased finished goods for resale |
–5,053 |
–3,739 |
–3,464 |
||
Marketing costs |
–5,777 |
–5,504 |
–5,207 |
||
Repairs and maintenance |
–2,436 |
–2,537 |
–2,227 |
||
IT, telephony and lease of premises |
–1,380 |
–1,445 |
–1,307 |
||
Other operating expenses, production |
–3,671 |
–3,291 |
–3,417 |
||
Other operating expenses, distribution, sales and administration |
–3,644 |
–3,090 |
–3,340 |
||
Other |
–560 |
–2,068 |
–659 |
||
Total |
–34 444 |
–33,242 |
–31,654 |
Other disclosures
Exchange rate effects had a negative impact of SEK –10m (–97; –189) on operating profit. Government grants received reduced operating expenses by SEK 65m (41; 47). Costs for research and development amounted to SEK –1,239m (–1,211; –1,055) during the period.